Immune responses to Plasmodium falciparum-merozoite surface protein 1 (MSP1) antigen, II. Induction of parasite-specific immunoglobulin G in unsensitized human B cells after in vitro T-cell priming with NSP119

Immunology

Volumn 97, Issue 3, 1999, Pages 497-505

  Garraud, O ^a   Diouf, A ^a   Holm, I ^b   Perraut, R ^a   Longacre, S ^b  

^a INSTITUT PASTEUR DE DAKAR   (Senegal)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; PARASITE ANTIGEN;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN DETECTION; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOMODULATION; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033010850     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00804.x     Document Type: Article

References (43)

1. 1. ENGERS H.D. & GODAL T. (1998) Malaria vaccine development. Parasitol Today 14, 56.
2. 2. GOOD M.F., KASLOW D.C. & MILLER L.H. (1998) Pathways and strategies for developing a malaria blood-stage vaccine. Annu Rev Immunol. 16, 57.
3. 3. PERRAUT R. & GARRAUD O. (1998) Essais vaccinaux et réponse immune contre Plasmodium falciparum chez le singe. Saimiri Méd Trop 58, 76.
4. 4. HOLDER A.A. & RILEY E.M. (1996) Human immune response to MSP-1. Parasitol Today 12, 173.
5. 5. EGAN A.F., MORRIS J., BARNISH G. et al. (1996) Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to three 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis 173, 765.
6. 6. KUMAR S., YADAVA A., KEISTER D.B. et al. (1995) Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Molec Med 1, 325.
7. 7. PERERA K.L.R.L., HANDUNNETTI S., HOLM I., LONGACRE S. & MENDIS K. (1998) Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria. Infect Immun 66, 1500.
8. 8. BURGHAUS P.A., WELLDE B.T., RICHARDS R.L. et al. (1996) Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface 1 protein in liposomes and alum adjuvant does not induce protection against a challenge infection. Infect Immun 64, 3614.
9. 9. NGUER C.M., DIALLO T.O., DIOUF A. et al. (1997) Plasmodium falciparum-and merozoite surface protein 1-specific antibody isotype balance in Senegalese immune adults. Infect Immun 65, 4873.
10. 10. DIEYE A., HEIDRICH H.G., ROGIER C. et al. (1993) Lymphocyte response in vitro to Plasmodium falciparum merozoite antigens in donors from a holoendemic area. Parasitol Res 79, 629.
11. 19 antigen. Immunology 97, 204.
12. 12. GARRAUD O., NKENFOU C., BRADLEY J.E. & NUTMAN T.B. (1996) Differential regulation of antigen-specific IgG4 and IgE antibodies in response to recombinant filarial proteins. Int Immunol 8, 1841.
13. 13. GARRAUD O., NKENFOU C., BRADLEY J.E., PERLER F.B. & NUTMAN T.B. (1995) Identification of recombinant filarial proteins capable of inducing polyclonal and antigen-specific IgE and IgG4 antibodies. J Immunol 155, 1316.
14. 14. CURTIS J.E., HERSCH E.M., BUTLER W.T. & ROSSEN R.D. (1971) Antigen dose in the human immune response: dose response relationship to the human immune response to keyhole limpet haemocyanin. J Lab Clin Med 75, 61.
15. 15. GARRAUD O., PERLER F.B., BRADLEY J.E. & NUTMAN T.B. (1997) Induction of parasite-specific antibody response in unsensitized human B cells is dependent on the presence of cytokines after T cell priming. J Immunol 159, 4793.
16. 16. HOLM I., NATO F., MENDIS K.N. & LONGACRE S. (1997) Characterization of C-terminal merozoite surface protein-1 baculovirus recombinant proteins from Plasmodium vivax and Plasmodium cynomolgi as recognized by the natural anti-parasite immune response. Mol Biochem Parasitol 89, 313.
17. 17. DRUILHE P., SABCHAERON A., BOUHAROUN-TAYOUN H., OEUVRAY C. & PERIGNON J.-L. (1997) In vivo veritas: lessons from immuno-globulin-transfer experiments in malaria patients. Ann Trop Med Parasitol 91, S37.
18. 18. GARRAUD O. & NUTMAN T.B. (1996) The role of cytokines in human B-cell differentiation into immunoglobulin-secreting cells. Bull Inst Pasteur 94, 285.
19. 19. BANCHEREAU J.T.B. & ROUSSET F. (1992) Human B lymphocytes: phenotype, proliferation, and differentiation. Adv Immunol 52, 125.
20. + (sIgD) B cells to secrete IgG1 and IgG3. J Exp Med 179, 757.
21. 21. PLEBANSKI M. & BURTLES S.S. (1992) In vitro primary responses of human T cells to soluble protein antigens. J Immunol Methods 170, 15.
22. 22. PLEBANSKI M., SAUNDERS M., BURTLES S.S., CROWE S. & HOOPER D.C. (1992) Primary and secondary human in vitro T-cell responses to soluble antigens are mediated by subsets bearing different CD45 isoforms. Immunology 75, 86.
23. + human T cells in vitro. J Immunol 160, 351.
24. 24. GUPTA M., SATYARAJ E., DURDIK J.M., RATH S. & BAL V. (1997) Differential regulation of T cell activation for primary versus secondary proliferate responses. J Immunol 158, 4113.
25. T cells in atopic patients. J Immunol 144, 4651.
26. 26. PARRONCHI P., MACCHIA D., PICCINI M.-P. et al. (1991) Allergenand bacterial antigen-specific T cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 88, 4538.
27. 27. MAHANTY S., KING C.L., KUMARASWAMI V. et al. (1993) II.-4 and IL-5 secreting lymphocyte populations are preferentially induced by parasite-derived antigens in human tissue invasive nematode infections. J Immunol 151, 3704.
28. 28. O'GARRA A. (1998) Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8, 275.
29. 29. BEN-SASSON S.Z., LE GROS G., CONRAD D.H., FINKELMAN F.D. & PAUL W.E. (1990) IL-4 production by T cells from naive donors; H.-2 is required for IL-4 production. J Immunol 145, 1127.
30. 30. ZHANG X.L., GIANGRECO L., BROOME H.E., DARGAN C.M. & SWAIN S.L. (1995) Control of CD4 effector fate: transforming growth factor ß1 and interleukin-2 synergize to prevent apoptosis and promote effector expansion. J Exp Med 182, 699.
31. 31. SWAIN S.L. (1995) CD4 T cell development and cytokine polarixation: an overview. J Leukocyte Biol 57, 795.
32. 32. COFFMANN R.L. & VON DER WEID T. (1997) Multiple pathways for the initiation of T helper 2 (Th2) responses. J Exp Med 185, 373.
33. + cells and primes for interleukin-4 production. Eur J Inmumol 27, 633.
34. + T cells. J Exp Med 185, 4641.
35. 35. SHARTON-KERSTEN T.M. & SHER A. (1997) Role of natural killer cells in innate resistance to protozoan infections. Curr Opin Immunol 9, 44.
36. + T cells. Immunology 93, 341.
37. 37. DOZMOROV I.M. & MILLER R.A. (1998) Generation of antigen-specific Th2 cells from unprimed mice in vitro: Effects of dexamethasone and anti-IL-10 antibody. J Immunol 160, 2700.
38. 38. ADA G. (1993) Vaccines. in Fundamental Immunology (ed. W. E. Paul), 3rd edn, p. 1309. Raven Press, New York.
39. 39. LANZAVECCIHA A. (1996). Mechanisms of antigen uptake for presentation. Curr Opin Immunol 8, 348.
40. 19 Antigens Differ in Their Capacities to Stimulate In Vitro Peripheral Blood T lymphocytes in Individuals from Various Endemic Areas. Scand J Immunol 49, 431.
41. 41. NOSSAI, G.J.V. (1992) The molecular and cellular basis of affinity maturation in the antibody response. Cell 68, 1.
42. 42. TAYLOR C.E. (1995) Cytokines as adjuvants for vaccines: antigen-specific responses differ from polyclonal responses. Infect Immun 63, 3241.
43. 43. MILLER L.H., GOOD M.F. & KASLOW D.C. (1997) The need for assays predictive of protection in the development of malaria blood stage vaccine. Parasitol Today 13, 46.